Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events

Author： Almeida Luis  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.64, Iss.6, 2008-06, pp. : 575-582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What can be done to improve patient safety in phase I trials?

By  

Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic evaluations alongside phase III trials?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 424, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Is animal testing a beneficial prelude to clinical trials?

By  

Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

NSAID-Related Psychiatric Adverse Events: Who is at Risk?

By Graziano Onder   Francesca Pellicciotti   Giovanni Gambassi   Roberto Bernabei  

Drugs, Vol. 64, Iss. 23, 2004-01 ,pp. : 2619-2627

Adis International

Access to resources Recommend Favorite

Is the use of placebos justified in advanced cancer trials?

By  

Inpharma, Vol. 1, Iss. 1548, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite